Skip to content

Clinical trials

Phase 2 Rhabdomyosarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rhabdomyosarcoma Phase: Phase 2 Country / region: United States Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20033
20062
20073
20084
20092
20102
20111
20122
20133
20141
20153
20162
20177
20184
20191
20204
20212
20225
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Active, not recruiting14
Terminated6
Recruiting3
Withdrawn3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)23
Memorial Sloan Kettering Cancer Center4
St. Jude Children's Research Hospital4
Brown University2
Children's National Research Institute2
Children's Oncology Group2
City of Hope Medical Center2
Eli Lilly and Company2
H. Lee Moffitt Cancer Center and Research Institute2
Sarcoma Alliance for Research through Collaboration2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rhabdomyosarcoma61
Sarcoma44
Osteosarcoma32
Sarcoma, Ewing31
Neuroblastoma29
Wilms Tumor21
Neuroectodermal Tumors, Primitive, Peripheral20
Medulloblastoma18
Ependymoma16
Hepatoblastoma16

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.